首页> Clinical cancer research : an official journal of the American Association for Cancer Research> A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial.

A Phase III Randomized Trial of Integrated Genomics and Avatar Models for Personalized Treatment of Pancreatic Cancer: The AVATAR Trial.

导出 OA

翻译打印收藏纠错

第一作者： Francesca,Sarno

第一单位： Hospital Universitario de Fuenlabrada, Madrid, Spain.

作者： Francesca,Sarno ^[1] ; Jair,Tenorio ^[2] ; Sofia,Perea ^[1] ; Laura,Medina ^[3] ; Roberto,Pazo-Cid ^[4] ; Ignacio,Juez ^[1] ; Rocío,Garcia-Carbonero ^[5] ; Jaime,Feliu ^[6] ; Carmen,Guillen-Ponce ^[7] ; Pedro P,Lopez-Casas ^[8] ; Carmen,Guerra ^[9] ; Yolanda,Duran ^[1] ; José Francisco,López-Acosta ^[1] ; Carolina,Alonso ^[1] ; Estrella,Esquivel ^[10] ; Ana,Dopazo ^[10] ; Dipikaa,Akshinthala ^[11] ; Senthil K,Muthuswamy ^[11] ; Pablo,Lapunzina ^[2] ; Bruno,Bockorny ^[12] ; Manuel,Hidalgo ^[13]

作者单位： Hospital Universitario de Fuenlabrada, Madrid, Spain. ^[1] CIBERER, Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.;INGEMM-IdiPAZ Institute of Medical and Molecular Genetics, Madrid, Spain.;ITHACA, European Reference Network, Brussels, Belgium. ^[2] UGCI Medical Oncology, Hospital Regional y Virgen de la Victoria, IBIMA, Malaga, Spain. ^[3] Hospital Universitario Miguel Servet, Zaragoza, Spain. ^[4] Hospital Universitario 12 de Octubre, Imas12, Facultad de Medicina UCM, Madrid, Spain. ^[5] Hospital Universitario La Paz, Madrid, Spain.;Instituto de Investigación Hospital Universitario La Paz (IdiPAZ), Madrid, Spain.;Universidad Autónoma de Madrid (UAM), Madrid, Spain.;Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain. ^[6] Hospital Universitario Ramon y Cajal, Madrid, Spain. ^[7] Instituto de Investigación Sanitaria, Hospital 12 de octubre (imas 12), Madrid, Spain. ^[8] Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.;Experimental Oncology Group, Molecular Oncology Program, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain. ^[9] Unidad de Genómica, Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain. ^[10] Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland. ^[11] Beth Israel Deaconess Medical Center, Boston, Massachusetts.;Harvard Medical School, Boston, Massachusetts. ^[12] Division of Hematology-Oncology, Weill Cornell Medical College, New York, New York.;New York-Presbyterian Hospital, New York, New York. ^[13]